| What it does | Equity Research & Market Intelligence
| Live business intelligence dashboards for healthcare leaders
|
|---|
| Stage | Not given
| Startup
|
|---|
| Founded | Not given
| 2026
|
|---|
| Based in | Not given
| AE
|
|---|
| Pricing model | Freemium
| Paid
|
|---|
| Pricing | Free: $0 forever. Analyst: $49/month. Research Pro: $89/month. Teams & Data: Custom contract pricing. Annual billing offers two months free. Seven-day free trial of Research Pro available with no card required.
| Not given
|
|---|
| Key features | - Reads and analyzes SEC filings (10-K, 10-Q, 8-K)
- Maps market events to affected companies via economic mechanisms
- Tracks 13F institutional holdings and insider Form 4 trades
- Provides verdict scores with reasoning and counter-thesis
- Earnings quality assessment and quarterly comparison
- Valuation analysis against peers and sector ranking
- Market-wide opportunity list and forming-theme radar
- Customizable watchlists with alerts on verdict changes
- Market-wide screening on insider activity, 13F flow and short interest
- iPhone app with synchronized research access
| - Real-time revenue, cost, gross profit and margin tracking with today, month-to-date and year-to-date views
- AI-driven intelligent alerts and predictive analysis
- Six integrated dashboards covering business health, finance, operations, insurance, HR and marketing
- Patient bookings, attendance and flow tracking
- Marketing metrics including new leads, CAC and campaign ROI
- Mobile app available on Google Play and App Store
- Integration with existing systems without replacement
- Insurance claims and revenue cycle visibility
|
|---|
| What makes it different | - Evidence-backed verdicts: every conclusion traces from market data through economic mechanisms to audited company fundamentals
- Continuous filing analysis: 77,956 SEC filings read and mapped, recomputed same-day when new filings arrive
- Timestamped decisions measured forward: verdicts are stamped when made, tracked at 1, 5 and 20 days to build earned track record
- One research workflow, not disconnected scores: market events stay connected from headline through mechanism to company fundamentals
- Every company searchable on all plans: no index restriction; plans differ only by depth of evidence, not which companies are visible
| - Live, real-time dashboards instead of periodic reports
- All key functions integrated on one platform
- Standalone subscription independent of advisory services
- Healthcare-specific design for GCC regulatory and operational requirements
|
|---|
| Community votes | 0 | 0 |
|---|
| DR (Domain Rating by Ahrefs) | 3 ▲ +1 (up) since last check | 5 ● no change since last check |
|---|
| Trust Flow (Majestic) | 0 | 2 |
|---|
| Citation Flow (Majestic) | 0 | 17 |
|---|
| Referring domains (Majestic) | 0 | 5 |
|---|
EquiReason
OzaniX Pulse